Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.41
+0.18 (3.44%)
Nov 22, 2024, 4:00 PM EST - Market closed
Solid Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -102.44 | -96.02 | -85.98 | -72.19 | -88.29 | -117.22 | Upgrade
|
| Depreciation & Amortization | 2.18 | 2.58 | 2.41 | 2.96 | 3.92 | 2.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.37 | 0.37 | - | 0.09 | - | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.94 | -2.41 | 0.23 | 1.12 | -0.02 | -0.28 | Upgrade
|
| Stock-Based Compensation | 8.64 | 7.63 | 7.54 | 13.37 | 11.63 | 14.21 | Upgrade
|
| Other Operating Activities | -0.15 | - | -18.49 | -0.08 | - | - | Upgrade
|
| Change in Accounts Receivable | - | - | 0.11 | -0.11 | - | - | Upgrade
|
| Change in Accounts Payable | 1.52 | -0.76 | -5.25 | 1.21 | -3.43 | 3.78 | Upgrade
|
| Change in Unearned Revenue | - | - | -8.08 | -12.64 | 20.72 | - | Upgrade
|
| Change in Other Net Operating Assets | -0.78 | -5.57 | 9.53 | -11.5 | -1.13 | 3.98 | Upgrade
|
| Operating Cash Flow | -91.19 | -94.18 | -97.98 | -77.76 | -56.6 | -92.71 | Upgrade
|
| Capital Expenditures | -0.54 | -1.52 | -3.02 | -1.28 | -0.9 | -4.39 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.6 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | 31.52 | - | - | - | Upgrade
|
| Investment in Securities | -8.82 | 11.2 | 30.05 | -89.81 | 7.5 | 28.9 | Upgrade
|
| Investing Cash Flow | -9.36 | 9.69 | 59.16 | -91.09 | 6.6 | 24.52 | Upgrade
|
| Long-Term Debt Issued | - | - | 2.14 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.07 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.35 | - | 2.08 | - | - | - | Upgrade
|
| Issuance of Common Stock | 121.46 | 3.12 | 72.75 | 134.99 | 132.49 | 49.33 | Upgrade
|
| Other Financing Activities | -5.11 | - | - | - | -3.79 | 8.55 | Upgrade
|
| Financing Cash Flow | 116 | 3.12 | 74.83 | 134.99 | 128.7 | 57.88 | Upgrade
|
| Net Cash Flow | 15.46 | -81.37 | 36.01 | -33.87 | 78.7 | -10.32 | Upgrade
|
| Free Cash Flow | -91.73 | -95.7 | -100.99 | -79.05 | -57.5 | -97.1 | Upgrade
|
| Free Cash Flow Margin | - | - | -1247.74% | -580.36% | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.61 | -4.81 | -11.86 | -11.10 | -16.61 | -36.15 | Upgrade
|
| Levered Free Cash Flow | -56.14 | -64.43 | -45.32 | -40.95 | -34.85 | -54.49 | Upgrade
|
| Unlevered Free Cash Flow | -56.14 | -64.43 | -45.32 | -40.95 | -34.85 | -54.49 | Upgrade
|
| Change in Net Working Capital | -3.64 | 7.93 | -6.75 | 10.84 | -4.54 | -7.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.